FLCO vs. CNCR ETF Comparison

Comparison of Franklin Liberty Investment Grade Corporate ETF (FLCO) to Loncar Cancer Immunotherapy ETF (CNCR)

FLCO

Franklin Liberty Investment Grade Corporate ETF

FLCO Description

The fund seeks to provide a high level of current income as is consistent with prudent investing, while seeking preservation of capital, by investing at least 80% of its net assets in investment grade corporate debt securities and investments. The Fund may invest up to 40% of its net assets in foreign securities, including those in developing markets, and up to 15% of its net assets in non-U.S. dollar denominated securities.

Grade (RS Rating)

Last Trade

$22.07

Average Daily Volume

219,533

Number of Holdings ^*

* may have additional holdings in another (foreign) market

CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$14.73

Average Daily Volume

4,200

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	FLCO	CNCR
30 Days	1.92%	-2.32%
60 Days	2.49%	3.51%
90 Days	5.42%	11.89%
12 Months	16.18%	40.02%

0 Overlapping Holdings

	Symbol	Grade	Weight in FLCO	Weight in CNCR	Overlap

FLCO Overweight 53 Positions Relative to CNCR

Symbol	Grade	Weight
BAC	D	2.39%
CAF	A	1.87%
LVS	B	1.81%
VZ	A	1.64%
BA	F	1.38%
BABA	A	1.24%
GJS	B	1.13%
EXC	A	1.11%
TAK	D	1.02%
CI	D	0.96%
PNC	C	0.93%
ABBV	A	0.92%
NOW	C	0.92%
CARR	A	0.9%
HCA	B	0.88%
FDX	D	0.86%
AAPL	C	0.85%
CMCSA	B	0.82%
MHK	B	0.8%
AFL	A	0.79%
TFC	D	0.77%
C	B	0.75%
ET	C	0.73%
UNH	B	0.72%
AL	D	0.68%
NOC	B	0.66%
GPJA	D	0.63%
MET	A	0.61%
ACGL	A	0.61%
CF	A	0.6%
KR	C	0.6%
AMZN	C	0.6%
JBL	D	0.58%
JWN	D	0.57%
FLEX	C	0.56%
XOM	A	0.55%
NWG	D	0.54%
DUK	A	0.51%
HII	F	0.49%
AON	A	0.49%
LMT	A	0.48%
DLTR	F	0.46%
CVX	B	0.44%
GPJA	D	0.4%
RPRX	B	0.4%
ALL	B	0.38%
AZO	D	0.37%
MSFT	D	0.35%
PSX	D	0.35%
DHI	C	0.33%
DVN	F	0.31%
WMB	A	0.3%
STZ	B	0.29%

FLCO Underweight 67 Positions Relative to CNCR

Symbol	Grade	Weight
SMMT	D	-6.48%
GERN	D	-3.44%
ELVN	B	-2.87%
NRIX	D	-2.41%
IGMS	C	-2.2%
FHTX	C	-2.17%
ACRV	D	-2.0%
RVMD	B	-1.88%
JANX	D	-1.87%
TYRA	C	-1.87%
KYMR	D	-1.78%
NUVB	F	-1.76%
ERAS	D	-1.75%
ACLX	C	-1.74%
REPL	B	-1.74%
AURA	C	-1.71%
BNTX	B	-1.71%
NUVL	B	-1.7%
TSVT	B	-1.7%
EXEL	B	-1.64%
REGN	D	-1.6%
MRUS	D	-1.51%
BCYC	D	-1.47%
BPMC	F	-1.44%
DAWN	D	-1.41%
ITOS	F	-1.39%
IMRX	D	-1.39%
IMTX	F	-1.38%
HCM	B	-1.38%
CGEM	F	-1.38%
GLUE	D	-1.37%
MRK	F	-1.35%
BMY	B	-1.34%
KURA	F	-1.29%
XNCR	D	-1.29%
RLAY	F	-1.28%
STRO	F	-1.26%
IPHA	F	-1.23%
YMAB	B	-1.22%
RCUS	F	-1.21%
GMAB	F	-1.12%
SNDX	F	-1.11%
IDYA	F	-1.06%
SDGR	F	-1.04%
LEGN	F	-0.98%
ACET	D	-0.98%
IOVA	F	-0.96%
PGEN	F	-0.95%
SWTX	F	-0.93%
LYEL	F	-0.91%
RPTX	D	-0.91%
RXRX	F	-0.87%
AUTL	F	-0.86%
ALLO	F	-0.84%
ARVN	F	-0.76%
PRLD	F	-0.75%
KPTI	D	-0.73%
IMCR	F	-0.72%
FATE	F	-0.71%
BMEA	D	-0.69%
VOR	F	-0.63%
MRSN	D	-0.55%
CRBU	F	-0.5%
GNLX	D	-0.49%
ZNTL	F	-0.4%
RAPT	F	-0.29%
MGNX	F	-0.27%

CNCR: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services Long-Term Care Facilities